US 10702473
Liposome formulation for delivery of Wnt signal pathway inhibitor
granted A61KA61K31/444A61K31/4725
Quick answer
US patent 10702473 (Liposome formulation for delivery of Wnt signal pathway inhibitor) held by Curegenix, Inc. expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Curegenix, Inc.
- Grant date
- Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/444, A61K31/4725, A61K31/496, A61K31/497